VIR
Vir Biotechnology
$11.93
+$0.36 (+3.11%)Oct 28, 2026
Key metrics
The numbers that frame VIR today
- Market cap
- $2.02B
- Gross margin
- 100%
- EV / Sales
- 6.0
- ROIC
- -31.3%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $4.82
- 52wk High
- $12.00
Growth
Revenue and earnings trend for VIR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about VIR
Is Vir Biotechnology a good buy?
Yes. Vir Biotechnology has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks strong, which supports the long-term business case. We think Vir Biotechnology is selling at a very high price, which cuts against the buy case.
What is the market capitalization of VIR?
Vir Biotechnology's market capitalization is $2.02B.
What is the 52-week high for VIR stock?
The 52-week high for Vir Biotechnology is $12.00. The current close of $11.93 is 0.6% below that high.
What is the 52-week low for VIR stock?
The 52-week low for Vir Biotechnology is $4.82. The current close of $11.93 is 147.8% above that low.
Does VIR stock pay dividends?
Vir Biotechnology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for VIR?
Vir Biotechnology's Debt / Equity ratio is 0.09.